Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Addressing quality and regulatory requirements for pharmaceutical applications.
Released By gChem
May 29, 2026
Widely used in the pharmaceutical industry for drug discovery, the synthesis of Active Pharmaceutical Ingredients (APIs), and analytical applications, Dimethyl Sulfoxide (DMSO) is a powerful solvent known for its ability to quickly penetrate skin and biological membranes. It’s also an excipient solvent in pharmaceutical drug delivery systems.
The exact purity of DMSO dictates whether it’s suitable and safe across different applications. DMSO is manufactured and classified into specific grades based on its intended use. As such, high-purity DMSO must meet strict regulatory requirements.
gChem is a premier manufacturer and leading innovator of DMSO. The company’s flagship product PROCIPIENT® (Dimethyl Sulfoxide USP, Ph. Eur.) addresses the quality and regulatory requirements, as required by the FDA, for these specific pharmaceutical applications.
Sandra Reid, Senior Director of Sales at gChem shares insight on high-purity DMSO grades, purity, and regulatory assurance, and understanding quality differentiation and manufacturing traceability.
Contract Pharma: How does gChem ensure products consistently meet the necessary specifications for their intended use?
Sandra Reid: At gChem we manufacture multiple grades of Dimethyl Sulfoxide in different manufacturing units, intended for different applications. What does not vary is our commitment to quality. We are dedicated to satisfying customer needs with high quality sustainable products and services for diverse markets around the world. For example, applications in life science market vary from the highest purity, sterile DMSO used in injectables (PROCIPIENT® Sterile) to high quality DMSO used for Active Pharmaceutical Ingredient (API) synthesis where the DMSO does not remain in the final API. Therefore, the purity, compliance, complexity, and manufacture of these varying grades, and applications in between, are different.
Product specifications vary between grades. Some examples are assay, water content, or UV absorbance. The specification is determined by the governing quality certification or registration of the grade of Dimethyl Sulfoxide. The Quality Management System maintains requirements for GMP manufacturing and ISO 9001 certification deemed essential for quality effectiveness. It is our goal to achieve 100% product delivery in-specification material, regardless of the specification. gChem follows an internal procedure securing customer approval of the product specification needed for their application. For every customer order, products undergo a thorough testing to be approved and released by the quality department. Products found to be out of spec are quarantined and managed with appropriate disposition procedures.
Product specifications for our PROCIPIENT® dimethyl sulfoxide are governed by its compliance to the USP and PhEur Monograph. This grade of DMSO is manufactured under cGMP conditions, in compliance with ICH Q7 guidelines. In contrast, for life science analytical applications we frequently recommend DMSO ACS Reagent Grade which maintains a tight specification governed by our own quality system, ISO 9001 certification. Regardless of your end-use in contract pharma, gChem will have our highest quality DMSO offering!
Contract Pharma: How does gChem ensure traceability within the excipient supply chain?
Sandra Reid: This is a great question. Excipients in respective countries have different standards but in no country is it required that excipients have the same requirement as an Active Pharmaceutical Ingredients. At gChem, we take the responsibility of safety, purity, and fitness for use as an excipient to the highest standard. Specifically for excipient use, we recommend PROCIPIENT®. Because we manufacture PROCIPIENT® under current Good Manufacturing Practices (cGMP) guidelines and we maintain a Type II Drug Master File (DMF) on file with the FDA, and DMF at Health Canada, and a CEP granted by EDQM, the product itself is an API. PROCIPIENT® provides audit, traceability and inspection history which is maintained by our quality department.
Contract Pharma: How does gChem foster partnerships with pharmaceutical developers to support drug development and enhance the quality of pharmaceutical products?
Sandra Reid: For all customers, enhancing safety specifically is an easy choice! If a formulator needs an aprotic solvent, DMSO is an obvious choice. We have data supporting the safety of DMSO compared with other solvent options. DMSO is not carcinogenic. DMSO is not mutagenic. And DMSO is not a reproductive toxin. DMSO is a naturally occurring substance, we just happen to manufacture it on purpose for its wide utility across many industries.
The quality of pharmaceuticals is always improving but what I see rapidly changing is the quality of the experience for the patient. For example, historical chemotherapy treatments involved intravenous administration that could take hours typically in a controlled environment. While I know this is still a necessary treatment for some, patients now have the option of immunotherapy subcutaneous injections which may take 5 minutes at a doctor’s office or even home administration. To me, this is enhancing quality of pharmaceuticals! A patient being able to self-administer a SC injection which may be possible because of PROCIPIENT® enhances our industry. Using a topical patch which delivers a necessary API because of PROCIPIENT® enhances our industry!
We love customers using DMSO and we love to help. In pharmaceutical development, it does get tricky as there is so much Intellectual Property at stake. At gChem, we strive to engage with customers as much as they desire. We support industry events and offer expertise on panels. We host webinars and articles such as this one in Contract Pharma. In fact, on May 29, 2026, Springer Publishing Company is publishing a book dedicated to DMSO titled ‘The Pharmaceutical Applications of Dimethyl Sulfoxide from Skin Penetration to Cell Therapy’ which had input from gChem experts. We are open to confidential discussions when appropriate. And we share public data available and our own private data if necessary. We look forward to working with you!
Contract Pharma: How can gChem DMSO be sourced?
Sandra Reid: We have a few options for sourcing. The first stop should be direct with gChem at www.gchemglobal.com or toll free (USA) at 800-426-6620. Online inquiries is a simple form that reaches sales within a few days. For toll free calls, please request to speak to a customer service representative. In the pharmaceutical industry, in North America, Spectrum Chemical is our exclusive distributor of PROCIPIENT® and other grades and in Europe and India, we partner with IMCD.
Contract Pharma: When sourcing gChem DSMO what indications, labels, paperwork, or certificates should a buyer request ensuring a high-quality product?
Sandra Reid: This is a great question and so critical for the pharmaceutical formulator to ensure they are sourcing a high-quality DMSO. There are few documents that are helpful to determine the source and manufacturing condition of the DMSO. Upon request, gChem will provide a COO which is a Certificate of Origin. This indicates the origin of the product. gChem is the only US manufacturer of DMSO to our knowledge. gChem’s manufacturing facility is audited by the FDA and we have a registered site which can be found on the FDA’s website Drug Establishments Current Registration Site. Gaylord Chemical LLC is a registered site and with proper internal approval we will share a statement regarding the latest FDA audit, date, and status. If a verified customer is filing an IND, NDA, or ANDA, gChem will share a Letter of Authorization (LOA) allowing the customer to reference product with their filing. gChem also has updated ISO certification for various grades of DMSO and this certification is shared with customers upon request. These are a few important differentiators that can help the client determine the manufacturing source, condition of which the DMSO is manufactured under, and the relevant status maintained.
For more information, gChem can be reached at go.gchemglobal.com/contractpharma2026 or toll free (USA) at 800-426-6620.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !